### 47698 Federal Register / Vol. 78, No. 151 / Tuesday, August 6, 2013 / Notices

the individual, organization, or other entity requesting a hearing; a brief statement of the requesting person’s interest in the Regional Administrator’s determination and a brief statement of the information that the requesting person intends to submit at such hearing; and the signature of the individual making the request, or, if the request is made on behalf of an organization or other entity, the signature of a responsible official of the organization or other entity.

**ADDRESSES :**  All documents relating to this determination are available for inspection between the hours of 8:00 a.m. and 4:30 p.m., Monday through Friday, at the following offices: Louisiana Department of Health and Hospitals, Office of Public Health, Bienville Building, 628 4th Street, Baton Rouge, LA 70821; and United States Environmental Protection Agency, Region 6, Drinking Water Section (6WQ–SD), 1445 Ross Avenue, Suite 1200, Dallas, Texas 75202.

**FOR FURTHER INFORMATION CONTACT :**  Amy Camacho, EPA Region 6, Drinking Water Section at the Dallas address given above, or by telephone at (214) 665–7175, or by email at camacho.amy@epa.gov.

Authority: Section 1413 of the Safe Drinking Water Act, as amended (1996), and 40 CFR part 142 of the National Primary Drinking Water Regulations.

Dated: July 19, 2013. Ron Curry, Regional Administrator.
[FR Doc. 2013–18945 Filed 8–5–13; 8:45 am]

**BILLING CODE 6560–50–P**

**FEDERAL DEPOSIT INSURANCE CORPORATION** 

**Notice to all Interested Parties of the Termination of the Receivership of**  **10183, 1st American State Bank of Minnesota Hancock, MN** 

Notice is hereby given that the Federal Deposit Insurance Corporation (‘‘FDIC’’) as Receiver for 1st American State Bank of Minnesota, Hancock, Minnesota (‘‘the Receiver’’) intends to terminate its receivership for said institution. The FDIC was appointed receiver of 1st American State Bank of Minnesota on February 05, 2010. The liquidation of the receivership assets has been completed. To the extent permitted by available funds and in accordance with law, the Receiver will be making a final dividend payment to proven creditors.

Based upon the foregoing, the Receiver has determined that the continued existence of the receivership will serve no useful purpose. Consequently, notice is given that the receivership shall be terminated, to be effective no sooner than thirty days after the date of this Notice. If any person wishes to comment concerning the termination of the receivership, such comment must be made in writing and sent within thirty days of the date of this Notice to: Federal Deposit Insurance Corporation, Division of Resolutions and Receiverships, Attention: Receivership Oversight Department 32.1, 1601 Bryan Street, Dallas, TX 75201.

No comments concerning the termination of this receivership will be considered which are not sent within this time frame.

Dated: August 1, 2013. Federal Deposit Insurance Corporation. Robert E. Feldman, Executive Secretary.
[FR Doc. 2013–18913 Filed 8–5–13; 8:45 am]

**BILLING CODE 6714–01–P**

**FEDERAL FINANCIAL INSTITUTIONS EXAMINATION COUNCIL** 

**[Docket No. AS13–19]**

**Appraisal Subcommittee Notice of Meeting** 

**AGENCY :**  Appraisal Subcommittee of the Federal Financial Institutions Examination Council.

**ACTION :**  Notice of meeting.

Description: In accordance with Section 1104 (b) of Title XI of the Financial Institutions Reform, Recovery, and Enforcement Act of 1989, as amended, notice is hereby given that the Appraisal Subcommittee (ASC) will meet in closed session:

**LOCATION :**  OCC—400 7th Street SW., Washington, DC 20024.

**DATE :**  August 14, 2013.

**TIME :**  Immediately following the ASC open session.

**STATUS :**  Closed.

**MATTERS TO BE CONSIDERED :**  July 10, 2013 minutes—Closed Session. Preliminary discussion of State

Compliance Reviews.
Dated: August 1, 2013. James R. Park,

Executive Director.
[FR Doc. 2013–18988 Filed 8–5–13; 8:45 am]

**BILLING CODE P FEDERAL FINANCIAL INSTITUTIONS**  **EXAMINATION COUNCIL**

**[Docket No. AS13–18]**

**Appraisal Subcommittee Notice of Meeting** 

**AGENCY :**  Appraisal Subcommittee of the Federal Financial Institutions Examination Council.

**ACTION :**  Notice of meeting.

**DESCRIPTION :**  In accordance with Section 1104 (b) of Title XI of the Financial Institutions Reform, Recovery, and Enforcement Act of 1989, as amended, notice is hereby given that the Appraisal Subcommittee (ASC) will meet in open session for its regular meeting:

**LOCATION :**  OCC—400 7th Street SW., Washington, DC 20024.

**DATE :**  August 14, 2013.

**TIME :**  10:30 a.m.

**STATUS :**  Open.

**MATTERS TO BE CONSIDERED :**  Summary Agenda July 10, 2013 minutes—Open Session

(No substantive discussion of the

above items is anticipated. These matters will be resolved with a single vote unless a member of the ASC requests that an item be moved to the discussion agenda.) Discussion Agenda: ASC 2014–18 Strategic Plan Delaware Compliance Review District of Columbia Compliance

Review Update on the Implementation of the

Policy Statements

How to Attend and Observe an ASC Meeting

Email your name, organization and contact information to meetings@asc.gov. You may also send a written request via U.S. Mail, fax or commercial carrier to the Executive Director of the ASC, 1401 H Street NW., Ste 760, Washington, DC 20005. The fax number is 202–289–4101. Your request must be received no later than 4:30 p.m., ET, on the Monday prior to the meeting. Attendees must have a valid government-issued photo ID and must agree to submit to reasonable security measures. The meeting space is intended to accommodate public attendees. However, if the space will not accommodate all requests, the ASC may refuse attendance on that reasonable basis. The use of any video or audio tape recording device, photographing device, or any other electronic or mechanical device designed for similar purposes is prohibited at ASC meetings.


### 47699 Federal Register / Vol. 78, No. 151 / Tuesday, August 6, 2013 / Notices

Dated: August 1, 2013. James R. Park,

Executive Director.
[FR Doc. 2013–18987 Filed 8–5–13; 8:45 am]

**BILLING CODE P**

**FEDERAL RESERVE SYSTEM**

**Formations of, Acquisitions by, and Mergers of Bank Holding Companies** 

The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq. ) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below.

The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States.

Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than August 30,
2013.

A. Federal Reserve Bank of San Francisco (Gerald C. Tsai, Director, Applications and Enforcement) 101 Market Street, San Francisco, California
94105–1579:

1. People’s Utah Bancorp, American Fork, Utah; to acquire 100 percent of the voting shares of Lewiston Bancorp, and thereby indirectly acquire voting shares of Lewiston State Bank, both in Lewiston, Utah.

Board of Governors of the Federal Reserve System, July 31, 2013. Michael J. Lewandowski, Associate Secretary of the Board.
[FR Doc. 2013–18857 Filed 8–5–13; 8:45 am]

**BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND**  **HUMAN SERVICES**

**Office of the Secretary**

**Findings of Research Misconduct**

**AGENCY :**  Office of the Secretary, HHS.

**ACTION :**  Notice.

**SUMMARY :**  Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following

case:

Pratima Karnik, Ph.D., Case Western Reserve University: Based on the admission of the Respondent, ORI found that Dr. Pratima Karnik, Assistant Professor, Department of Dermatology, Case Western Reserve University (CWRU), engaged in research misconduct in research submitted to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), in grant application R01 AR062378.

ORI found that the Respondent engaged in research misconduct by plagiarizing significant portions from research grant application R21 AR061881 that she had reviewed for NIAMS, NIH, and inserting that text into her submitted grant application R01 AR062378–01. Respondent also plagiarized significant portions of text from the following scientific articles and one U.S. patent application available on the Internet:

• BMC Med Genomics 4:8, 2011

• J Am Col. Cardiol 52:117–123, 2008

• Nature 457:910–914, 2009

• J Autoimmun 29:310–318, 2007

• U.S. Patent Application No. 20090047269 (published Feb. 19, 2009)

• Toxicol Pathol 35:952–957, 2007

• BMC Med Genomics 1:10, 2008

• Open Systems Biology Journal 1:1– 8, 2008

• Endocrinology 146:4189–4191,
2005.

• Dr. Karnik has entered into a Voluntary Settlement Agreement and has voluntarily agreed for a period of two (2) years, beginning on July 22,
2013:

(1) To have her research supervised; Respondent agreed that prior to the submission of an application for U.S. Public Health Service (PHS) support for a research project on which her participation is proposed and prior to her participation in any capacity on PHS-supported research, Respondent shall ensure that a plan for supervision of her duties is submitted to ORI for approval; the supervision plan must be designed to ensure the scientific integrity of her research contribution; she agreed that she shall not participate in any PHS-supported research until such a supervision plan is submitted to and approved by ORI; Respondent agreed to maintain responsibility for compliance with the agreed upon supervision plan;

(2) That any institution employing her shall submit in conjunction with each application for PHS funds, or report,manuscript, or abstract involving PHSsupported research in which Respondent is involved, a certification to ORI that the content is free of plagiarized material, data provided by Respondent are based on actual experiments or are otherwise legitimately derived, and that the data, procedures, and methodology are accurately reported in the application, report, manuscript, or abstract; and

(3) To exclude herself voluntarily from serving in any advisory capacity to PHS including, but not limited to, service on any PHS advisory committee, board, and/or peer review committee, or as a consultant.

**FOR FURTHER INFORMATION CONTACT :**  Director, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8200.

David E. Wright, Director, Office of Research Integrity.
[FR Doc. 2013–18979 Filed 8–5–13; 8:45 am]

**BILLING CODE 4150–31–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**[30 Day-13–13IF]**

**Agency Forms Undergoing Paperwork Reduction Act Review** 

The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call (404) 639–7570 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project

Pilot Project to Evaluate the Use of Exposure Control Plans for Bloodborne Pathogens in Private Dental Practices –New- National Institute for